A multicenter, nonrandomized, historical controlled study in patients with de novo coronary artery lesions in small vessels treated with the Cypher stent.
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms SVELTE
- Sponsors Cordis Corporation
- 15 Sep 2008 Actual patient number (100) added as reported by ClinicalTrials.gov.
- 15 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2007 New trial record.